Table 1.
Brain tissues analyzed in this study from diseased and age-matched control subjects.
| Clinical diagnosis | Case number | Age | Gender | PMI (h) | Braak stage (0-6) | Application |
|---|---|---|---|---|---|---|
| ALS | 2489 | 64 | M | 17 | 1 | IF/WB |
| ALS | 2498 | 68 | M | 24 | 1 | IF/WB |
| ALS | 1661 | 84 | M | 30 | 0 | Filter trap |
| ALS | 1779 | 65 | F | 9 | N/A | IF/WB |
| ALS | 1942 | 73 | F | 14 | N/A | WB |
| ALS | 1589 | 76 | F | 9 | N/A | WB |
| ALS | 1934 | 66 | F | 23 | N/A | WB |
| FTD | 1836 | 56 | F | 21 | 0 | IF/WB |
| FTD | 1841 | 60 | M | 7 | 0 | IF/WB/Filter trap |
| FTD | 5766 | 81 | M | 14 | IF/WB | |
| FTD | 5827 | 80 | F | 7 | 0 | WB |
| FTD | 5853 | 71 | M | N/A | N/A | WB |
| FTD | 5806 | 57 | F | 10 | N/A | WB |
| AD | 1120 | 83 | F | 4.75 | 6 | IF |
| AD | 1154 | 86 | M | 3.25 | 6 | IF |
| AD | 1098 | 81 | F | 2.75 | 5 | IF/WB/Filter trap |
| AD | 1964 | 67 | F | 33 | 6 | WB |
| AD | 5773 | 74 | M | 10 | 5 | WB |
| AD | 5779 | 73 | M | 15 | 6 | WB |
| AD | 5781 | 88 | M | 10 | 5 | WB |
| AD | 5829 | 68 | M | 12 | 6 | WB |
| Control | 5263 | 88 | M | 12.17 | 1 | IF |
| Control | 1161 | 84 | F | 2.50 | 0 | IF |
| Control | 1106 | 79 | M | 1.75 | 2 | IF/WB/Filter trap |
| Control | 1796 | 81 | M | 8 | 0 | WB |
| Control | 25-01 | N/A | N/A | N/A | 2 | WB |
| Control | 19-01 | N/A | N/A | N/A | 2 | WB |
| Control | 2-99 | 74 | F | 2.8 | 2 | WB |
| Control | 13-01 | 95 | M | 3.7 | 1 | WB |
WB western blot, IF iImmunofluorescence